KIMBERLY OBERLOH: Open Payments
NPI 1699159186 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 20 payments from 13 companies in 2025. Trend: 2023 $276 · 2024 $589 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $144 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Neuronetics, Inc. | 1 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| HARMONY BIOSCIENCES LLC | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
Products named: REZDIFFRA, Auvelity, INGREZZA, AUSTEDO XR, NEUROSTAR TMS THERAPY SYSTEM, Jornay PM, CAPLYTA, TRINTELLIX.
Industry payments across SD — which companies pay providers there.
